id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-D-2074-0021,FDA,FDA-2018-D-2074,"Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C Guidance for Industry and FDA Staff",Other,Guidance,2022-03-04T05:00:00Z,2022,3,2022-03-04T05:00:00Z,,2024-11-12T23:39:20Z,,1,0,0900006484fba142
FDA-2018-D-2074-0020,FDA,FDA-2018-D-2074,Initiation of Voluntary Recalls; Guidance for Industry and Food and Drug Administration Staff; Availability,Rule,Extension of Comment Period,2022-03-04T05:00:00Z,2022,3,2022-03-04T05:00:00Z,,2022-03-04T15:28:38Z,2022-04704,0,0,0900006484fb9d95
FDA-2018-D-2074-0002,FDA,FDA-2018-D-2074,"Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C Guidance for Industry and FDA Staff DRAFT GUIDANCE",Other,Guidance,2019-04-25T04:00:00Z,2019,4,2019-04-25T04:00:00Z,,2024-11-12T22:59:46Z,,1,0,0900006483bf6be0
FDA-2018-D-2074-0001,FDA,FDA-2018-D-2074,Initiation of Voluntary Recalls Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Proposed Rule,GDL Guidance,2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,2019-06-25T03:59:59Z,2019-06-25T01:01:12Z,2019-08198,0,0,0900006483be94d9